ENFUSION, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.54 USD | -1.04% |
|
+6.08% | -1.03% |
| May. 09 | Enfusion Shares Fall Despite Higher Q1 Results | MT |
| May. 09 | Transcript : Enfusion, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,373 | 667.1 | 856.3 | 886 | - | - |
| Enterprise Value (EV) 1 | 1,309 | 604.6 | 820.7 | 831.9 | 794.8 | 753.1 |
| P/E ratio | -9.27 x | -96.7 x | 139 x | 127 x | 57.3 x | 48.3 x |
| Yield | - | - | - | 0.05% | - | - |
| Capitalization / Revenue | 12.3 x | 4.44 x | 4.91 x | 4.31 x | 3.65 x | 3.13 x |
| EV / Revenue | 11.7 x | 4.02 x | 4.7 x | 4.05 x | 3.27 x | 2.66 x |
| EV / EBITDA | 57.1 x | 30.7 x | 26.1 x | 19.4 x | 13.9 x | 10.5 x |
| EV / FCF | -157 x | 97.1 x | 51.4 x | 34.3 x | 17.6 x | - |
| FCF Yield | -0.64% | 1.03% | 1.95% | 2.91% | 5.69% | - |
| Price to Book | 42.8 x | 17 x | 23.1 x | 12.1 x | 7.72 x | 7.03 x |
| Nbr of stocks (in thousands) | 65,583 | 68,986 | 88,280 | 91,911 | - | - |
| Reference price 2 | 20.94 | 9.670 | 9.700 | 9.640 | 9.640 | 9.640 |
| Announcement Date | 3/24/22 | 3/7/23 | 3/12/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 79.56 | 111.7 | 150.3 | 174.5 | 205.4 | 243.1 | 283.1 |
| EBITDA 1 | - | 22.91 | 19.72 | 31.47 | 42.8 | 57.02 | 71.94 |
| EBIT 1 | - | -274.7 | 13.03 | 19.41 | 31.71 | 44.72 | 57.57 |
| Operating Margin | - | -245.9% | 8.67% | 11.12% | 15.44% | 18.4% | 20.34% |
| Earnings before Tax (EBT) 1 | - | -281.7 | -12.19 | 11.48 | 12.36 | 24.91 | - |
| Net income 1 | 4.061 | -282.2 | -13.26 | 6.025 | 12.43 | 24.71 | - |
| Net margin | 5.1% | -252.68% | -8.82% | 3.45% | 6.05% | 10.16% | - |
| EPS 2 | - | -2.260 | -0.1000 | 0.0700 | 0.0761 | 0.1683 | 0.1998 |
| Free Cash Flow 1 | - | -8.332 | 6.225 | 15.96 | 24.25 | 45.25 | - |
| FCF margin | - | -7.46% | 4.14% | 9.15% | 11.8% | 18.62% | - |
| FCF Conversion (EBITDA) | - | - | 31.57% | 50.72% | 56.66% | 79.35% | - |
| FCF Conversion (Net income) | - | - | - | 264.95% | 195.03% | 183.15% | - |
| Dividend per Share 2 | - | - | - | - | 0.005110 | - | - |
| Announcement Date | 9/17/21 | 3/24/22 | 3/7/23 | 3/12/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 31.85 | 34.14 | 36.54 | 39.15 | 40.52 | 40.97 | 42.72 | 44.36 | 46.49 | 48.05 | 49.93 | 52.34 | 55.3 | 57.06 | 59.72 |
| EBITDA 1 | 3.192 | 2.088 | 5.428 | 5.435 | 6.764 | 5.703 | 7.954 | 8.028 | 9.787 | 9.179 | 9.918 | 11.05 | 12.96 | 12.23 | 13.5 |
| EBIT 1 | -291.3 | 0.311 | 3.762 | 3.774 | 5.577 | 3.532 | 5.085 | 5.251 | 5.538 | 5.888 | 7.217 | 8.199 | 9.799 | 9.386 | 10.59 |
| Operating Margin | -914.46% | 0.91% | 10.3% | 9.64% | 13.76% | 8.62% | 11.9% | 11.84% | 11.91% | 12.25% | 14.45% | 15.67% | 17.72% | 16.45% | 17.74% |
| Earnings before Tax (EBT) 1 | -294 | -12.37 | -3.906 | 2.885 | 1.206 | 5.09 | 1.186 | 3.028 | 2.18 | -0.878 | 3.975 | 4.8 | 5.95 | 2.062 | 7.306 |
| Net income 1 | -293.9 | -7.265 | -2.422 | 1.539 | 0.788 | 2.945 | 0.629 | 1.828 | 0.623 | -0.539 | 2.987 | 3.745 | 6.351 | 3.071 | 7.306 |
| Net margin | -922.66% | -21.28% | -6.63% | 3.93% | 1.94% | 7.19% | 1.47% | 4.12% | 1.34% | -1.12% | 5.98% | 7.16% | 11.49% | 5.38% | 12.23% |
| EPS 2 | -2.260 | -0.1000 | -0.0300 | 0.0200 | 0.0100 | 0.0400 | 0.0100 | 0.0200 | 0.0100 | -0.0100 | 0.0149 | 0.0241 | 0.0422 | 0.0277 | 0.0435 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/24/22 | 5/12/22 | 8/9/22 | 11/10/22 | 3/7/23 | 5/9/23 | 8/8/23 | 11/7/23 | 3/12/24 | 5/9/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 64.4 | 62.5 | 35.6 | 54.1 | 91.2 | 133 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -8.33 | 6.23 | 16 | 24.3 | 45.3 | - |
| ROE (net income / shareholders' equity) | - | - | -15.1% | 20.3% | 32.6% | 29.3% | 26% |
| ROA (Net income/ Total Assets) | - | - | - | 10.3% | 23.9% | 25.8% | - |
| Assets 1 | - | - | - | 58.27 | 52.03 | 95.91 | - |
| Book Value Per Share 2 | - | 0.4900 | 0.5700 | 0.4200 | 0.8000 | 1.250 | 1.370 |
| Cash Flow per Share 2 | - | -0 | 0.1700 | 0.2000 | 0.2500 | 0.3100 | - |
| Capex 1 | - | 8.01 | 7.93 | 9.67 | 9.61 | 10.5 | 13.2 |
| Capex / Sales | - | 7.17% | 5.28% | 5.54% | 4.68% | 4.33% | 4.67% |
| Announcement Date | 9/17/21 | 3/24/22 | 3/7/23 | 3/12/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
9.64
USD
Average target price
9.821
USD
Spread / Average Target
+1.88%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.62% | 886M | |
| +11.94% | 3,129B | |
| +10.56% | 86.84B | |
| +6.08% | 78.63B | |
| -15.16% | 53.93B | |
| +26.21% | 48.21B | |
| -23.40% | 47.43B | |
| +29.50% | 45.58B | |
| +76.40% | 41.03B | |
| -9.24% | 24.92B |
- Stock Market
- Equities
- ENFN Stock
- Financials Enfusion, Inc.